7-57463081-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001159279.1(ZNF716):c.175G>A(p.Val59Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,609,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001159279.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF716 | NM_001159279.1 | c.175G>A | p.Val59Ile | missense_variant | 3/4 | ENST00000420713.2 | NP_001152751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF716 | ENST00000420713.2 | c.175G>A | p.Val59Ile | missense_variant | 3/4 | 4 | NM_001159279.1 | ENSP00000394248 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000704 AC: 107AN: 152092Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000221 AC: 54AN: 244272Hom.: 0 AF XY: 0.000203 AC XY: 27AN XY: 133006
GnomAD4 exome AF: 0.0000707 AC: 103AN: 1457198Hom.: 0 Cov.: 31 AF XY: 0.0000676 AC XY: 49AN XY: 725054
GnomAD4 genome AF: 0.000703 AC: 107AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000712 AC XY: 53AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.175G>A (p.V59I) alteration is located in exon 3 (coding exon 3) of the ZNF716 gene. This alteration results from a G to A substitution at nucleotide position 175, causing the valine (V) at amino acid position 59 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at